Literature DB >> 8753849

Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients.

P Chanez1, I Enander, I Jones, P Godard, J Bousquet.   

Abstract

Interleukin 8 (IL-8) is a chemoattractant cytokine having a distinct target specificity for the neutrophil. However, it was also found to be active on primed eosinophils. IL-8 was measured by enzyme immunoassay in the bronchoalveolar lavage fluid (BALF) of 9 control subjects, 19 asthmatics and 36 chronic bronchitis patients. Its levels were correlated with neutrophil and eosinophil counts as well as levels of myeloperoxidase (MPO) and eosinophil cationic protein in the BALF. Asthmatic and chronic bronchitis patients had elevated levels of IL-8 in comparison with normal subjects. There was no correlation between the severity of asthma or chronic bronchitis and IL-8 levels. In asthmatic subjects there was a correlation between IL-8 and MPO levels (p < 0.0001, Spearman test). There was no significant correlation between eosinophils and IL-8. In chronic bronchitis there was a correlation between IL-8 and MPO levels as well as between IL-8 and neutrophil counts (p < 0.004 and p < 0.0152, respectively, Spearman test). IL-8 is involved in neutrophilic inflammation in asthma and chronic bronchitis, but differences in the IL-8 regulation of neutrophils were observed in both diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753849     DOI: 10.1159/000237350

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  11 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Onset and outcome of asthma in older adults. A clinician's perspective.

Authors:  Charles E Reed
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

3.  Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

4.  Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients.

Authors:  M J Leckie; S A Bryan; J Khan; A Dewar; S L Aikman; J McGrath; D A Okrongly; J F Burman; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

5.  Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation.

Authors:  G T De Sanctis; J A MacLean; S Qin; W W Wolyniec; H Grasemann; C N Yandava; A Jiao; T Noonan; J Stein-Streilein; F H Green; J M Drazen
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Involvement of polycyclic aromatic hydrocarbons and endotoxin in macrophage expression of interleukin-33 induced by exposure to particulate matter.

Authors:  Nami Ishihara; Tomoaki Okuda; Hiroyuki Hagino; Ami Oguro; Yuto Tani; Hiroshi Okochi; Chiharu Tokoro; Yoshiaki Fujii-Kuriyama; Kouichi Itoh; Christoph F A Vogel; Yasuhiro Ishihara
Journal:  J Toxicol Sci       Date:  2022       Impact factor: 1.792

7.  Elevated Serum Interleukin-8 Level as a Preferable Biomarker for Identifying Uncontrolled Asthma and Glucocorticosteroid Responsiveness.

Authors:  Jingxi Zhang; Chong Bai
Journal:  Tanaffos       Date:  2017-06

8.  PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells.

Authors:  Sara S Roscioni; Loes E M Kistemaker; Mark H Menzen; Carolina R S Elzinga; Reinoud Gosens; Andrew J Halayko; Herman Meurs; Martina Schmidt
Journal:  Respir Res       Date:  2009-09-29

9.  Serum Levels of Interleukin-8 and Tumor Necrosis Factor-alpha in Coal Workers' Pneumoconiosis: One-year Follow-up Study.

Authors:  Jong Seong Lee; Jae Hoon Shin; Joung Oh Lee; Kyung Myung Lee; Ji Hong Kim; Byung-Soon Choi
Journal:  Saf Health Work       Date:  2010-09-30

Review 10.  Neutrophils in asthma pathophysiology.

Authors:  Madeleine Ennis
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.